US hospitals to ask patients for right to sell their tissueBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7262.653 (Published 16 September 2000) Cite this as: BMJ 2000;321:653
- Deborah Josefson
- San Francisco
Several academic hospitals in the United States are forming partnerships with biotechnology companies to provide them with human tissue for research, treatment, and drug development purposes, in a series of arrangements which raise wide legal and ethical issues.
Harvard University's Beth Israel Deaconess Medical Center in Boston and the Duke University Medical Center in North Carolina are among the latest academic hospitals to join such ventures.
Both of these institutions have entered into agreements with Ardais, a genomics startup company, which …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial